News About: Pharm. Industry
Huons profits increase 1,185% in 2011
Huons Pharma’s last year sales increased by 12 percent, while its operating profits for the period increased by 1,185 percent compared to the same period last year.
The company’s sales figure for the period came in...
Dong-A drooling over future profits
The imminent additional reclassification of 20 over-the-counter (OTC) drugs as “quasi-drugs,” is seen as a much needed move for the industry, but not everyone is going to benefit from it.
A parliamentary health sub...
Large drug makers scrambling to increase R&D spending
Major pharmaceutical firms seek to expand their corporate investment in research and development (R&D) as part of efforts to be selected in one of innovative drug firms.
The Ministry of Health and Welfare unveiled ...
Green Cross overtaken by Daewoong in 2011 sales rank
Daewoong Pharmaceutical has finally overtaken Green Cross Corp. in 2011 revenue, pushing the latter down to the third place.
According to Yakup.com, Daewoong posted revenues of 711.1 billion won last year, while Do...
KIPO to offer patent related consulting service for smaller drug markers
The country’s pharmaceutical companies face tough times ahead with the new Korea-U.S. Free Trade Agreement poised to strengthen patent rights for U.S. drug giants, heaping strain on the generic-focused Korean industry...
Two women at drug firm challenge youth politics
Two women at drug firms applied for the “youth proportional representation” program, which is adopted by Democratic United Party as a new method in its candidate nomination process for the April 11 general elections.
...
Ilsung president to run for KPMA’s next president
Ilsung Pharmaceutical President Yoon suk-geun said he want to be the next president of the Korea Pharmaceutical Association.
In a press interview Monday, Yoon said it will steer change in the KPMA.
“I want to be...
Major Firms’ sales inch up, profitability down in 2011
Pharmaceutical major companies saw their revenues edge up last year.
But their ability to generate cash from a variety of operating activities fell on worsening profitability as a result of the government’s tight ...
Korea United bring out clopidogrel plus aspirin brand
Korea United Pharm is bringing Clavixin Duo capsule, a combination of clopidogrel and aspirin, to the nation thus expanding its business horizons beyond the traditional pharmaceutical segment.
The company held its...
Local drugmakers urged to seek overseas expansion
Many experts paint a gloomy picture for the Korean pharmaceutical industry that awaits a policy to slash drug prices this year.
So far, attention has been drawn on who will break a trillion-won barrier in sales in ...
